Reduced rate of disease development after HIV-2 infection as compared to HIV-1.

Marlink, R; Kanki, P; Thior, I; Travers, K; Eisen, G; Siby, T; Traore, I; Hsieh, C C; Dia, M C; Gueye, E H

Marlink, R; Kanki, P; Thior, I; Travers, K; Eisen, G; Siby, T; Traore, I; Hsieh, C C; Dia, M C; Gueye, E H.

Affiliation

Marlink R; Department of Cancer Biology, Harvard School of Public Health, Boston, MA 02115.

Science ; 265(5178): 1587-90, 1994 Sep 09.

Article in En | MEDLINE | ID: mdl-7915856

Subject(s)

Acquired Immunodeficiency Syndrome/microbiology; HIV Infections/microbiology; HIV-1/pathogenicity; HIV-2/pathogenicity; Acquired Immunodeficiency Syndrome/epidemiology; Acquired Immunodeficiency Syndrome/immunology; Adult; CD4-Positive T-Lymphocytes; Cohort Studies; Female; HIV Infections/epidemiology; HIV Infections/immunology; Humans; Immune Tolerance; Incidence; Leukocyte Count; Prospective Studies; Senegal/epidemiology; Virulence

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: HIV Infections / Acquired Immunodeficiency Syndrome / HIV-1 / HIV-2 Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans Country/Region as subject: Africa Language: En Journal: Science Year: 1994 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links